Pyridinyl compounds useful as intermediates
US8338610B2 · kind B2 · utility
8Cited by
34References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2012 |
| Grant date | Dec 25, 2012 |
| Priority date | — |
| Expiry date | Feb 8, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of the formula (I), useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.Also disclosed are intermediates thereof, and methods of making and methods of using same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.